Has the Food and Drug Administration (FDA) become little more than a rubber stamp for pharmaceutical companies or will new changes provide a check and balance on the industry? According to a Washington Post assessment of a recent study, "the federal system for approving and regulating drugs is in serious disrepair, and a host of dramatic changes are needed to fix the problem.
For more information on Sheller, P.C., visit www.sheller.com.
Link to this comment:
All Comments (0)